CACLP 2025 Unites Global Innovators in IVD Industry

Over 1,300 exhibitors will present their cutting-edge technologies across seven major categories spanning Halls 2 to 8, with more than 60 companies launching their new products onsite. CACLP 2025 will also feature dedicated Canada and Germany Pavilions, highlighting the leading diagnostic companies and innovations from North America and Europe. Government entities, medical associations, and industry organizations from countries including Canada, Germany, India, South Korea, Switzerland, the U.K., the U.S., Vietnam and beyond will actively participate, contributing to onsite discussions, especially dozens of regulatory and product innovations roadshows in the Presentation Area of Halls 5 and 7. With professional visitors and international buyers recruited from key markets worldwide, CACLP 2025 will serve as a premier platform for global networking and cross-border collaboration.

As a hub for AI and technology advancements, Hangzhou provides the perfect backdrop for CACLP 2025, which will introduce the 1st AI and Digital Twin Technology Academic Salon, exploring the transformative role of AI in diagnostics. Additionally, onsite activities will spotlight many key industry trends, including veterinary diagnostics, global investment, and primary healthcare. The event will debut three groundbreaking forums addressing critical industry shifts. The 1st Human-to-Animal Medical Device Transition Forum, co-hosted with the East and West Small Animal Veterinary Conference, will examine how human diagnostic innovations are shaping the veterinary healthcare market, with a focus on standardization, regulations, and commercialization. The 1st National Primary Healthcare Laboratory Forum addresses quality control, test result standardization, and access to advanced diagnostics, supporting the growth of grassroots laboratory services. The 1st China IVD Companies Globalization Forum will feature insights from government officials, regulatory experts, and industry leaders, providing strategic guidance on global market trends, regulatory pathways, and international expansion.

In addition to the exhibition and newly launched activities, CACLP remains a hub for academic and industry dialogues. Further high-level conferences and forums will be primarily held in Hall 1 – the Convention Center. The 10th China Experimental Medicine Conference (CEMC), themed "A Decade Together for a Shared Future", will bring together leading academicians, hospital presidents, and experts in experimental medicine and biomedical engineering. Discussions will cover early disease screening, personalized treatment, AI integration, and other cutting-edge advancements. The conference will also feature sessions dedicated to pathology, molecular diagnostics, coagulation, mass spectrometry, and more specific topics. The 12th China IVD Industry Development Conference (CIIDC), under the theme "Empowering the Future with New Intelligence", will explore the future of the IVD industry through discussions on sustainability, international expansion, healthcare reforms, technological advancements, investment strategies, and industry development.

A key highlight will be the official release of the Annual Report of China IVD Industry 2024, providing essential insights into market performance and trends. Additional forums including Enlightening Lab Med – The 8th IVD Youth Entrepreneur Forum (ELMY), the 7th China IVD Distribution Enterprise Forum (CIDEF), and the 5th China Key Raw Material & Parts Forum (CKRMPF), will offer targeted discussions for different segments of the IVD industry. With two main tradeshows and over 100 concurrent activities, and unmatched networking opportunities, CACLP 2025 is the go-to event for professionals in diagnostics, laboratory medicine, and healthcare.

Related Links:
CACLP